A clinical trial for the pill showed that participants who took the full course of treatment over 64 weeks experienced an average weight loss of around 17%, compared to 3% weight loss in a placebo group
News articles abound about the fears around high prices for GLP-1s, and Senators are claiming the prices are unjustifiably high because of how many patients could benefit from them if they were cheaper
Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes
This broader targeting allows retatrutide to potentially offer greater weight loss and metabolic benefits
[DOI] [PMC free article] [PubMed] [Google Scholar] 39.Gerstein H.C., Sattar N., Rosenstock J., Ramasundarahettige C., Pratley R., Lopes R.D., Lam C.S.P., Khurmi N.S., Heenan L., Del Prato S., et al